Skip to main content
Stephen Gitelman, MD, Pediatric Endocrinology, San Francisco, CA, UCSF Medical Center

StephenE.GitelmanMD

Pediatric Endocrinology San Francisco, CA

Clinical Professor of Pediatrics, UCSF

Are you Dr. Gitelman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 53 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Stephen Gitelman, MD is a pediatric endocrinologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with UCSF Medical Center and UCSF Benioff Children's Hospital Oakland.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Pediatric Cardiology, 1987 - 1990
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 1984 - 1987
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2024
  • American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • UCSF Researchers Working on Approval of Breakthrough Diabetes Therapy
    UCSF Researchers Working on Approval of Breakthrough Diabetes TherapyDecember 21st, 2022
  • Cancer Drug May Slow Course of Type-1 Diabetes
    Cancer Drug May Slow Course of Type-1 DiabetesJuly 19th, 2021
  • Immunotherapy Delays Type 1 Diabetes Onset in People at High Risk
    Immunotherapy Delays Type 1 Diabetes Onset in People at High RiskJune 9th, 2019
  • Join now to see all

Grant Support

  • K12 In Diabetes (KIDS)National Institute Of Diabetes And Digestive And Kidney Diseases2011
  • UCSF Trialnet: A Phase II Trial Of Imatimib In New Onset Type I DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • UCSF Trialnet: A Phase II Trial Of Hokt3gamma1 (Ala-Ala)National Institute Of Diabetes And Digestive And Kidney Diseases2001–2007
  • Trialnet Natural History Study Of The Development Of Type 1 DiabetesNational Center For Research Resources2005
  • The Type 1 Diabetes Genetics Consortium ProtocolNational Center For Research Resources2005
  • Pilot Study On The Effect Of Oral Alpha-Lipoic Acid On Oxidative Stress In T1dmNational Center For Research Resources2005
  • Immune Tolerance Network Pilot 2 Protocol NO Lpl12National Center For Research Resources2005
  • Use Of Continuous Glucose Monitoring In Infants And Children With HypoglycemiaNational Center For Research Resources2004–2005
  • T Cell Assays In Type 1 Diabetes MellitusNational Center For Research Resources2004–2005
  • Hoktt3yl (Ala Ala) In Participants With Type 1 Diabetes MellitusNational Center For Research Resources2004–2005
  • A Multicenter, Randomized Double Blind Trial Of Metformin In Obese AdolescentsNational Center For Research Resources2004–2005
  • Measurement Of Insulin Secretory Response To A Mixed Meal In Normal IndividualsNational Center For Research Resources2004
  • Immune Tolerance Network Pilot 2 Protocol NO. Lpl12National Center For Research Resources2004
  • CRF In The Diagnosis And Longterm Management Of Pediatric Cushing'S DiseaseNational Center For Research Resources1998–2002
  • Vgr-1/Bmp-6 And Chondrogenesis And OsteogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–1997
  • CRF In Diagnosis And Long Term Management Of Pediatric Cushing'S DiseaseNational Center For Research Resources1996
  • CRF In Diagnosis And Management Of Pediatric Cushing'S DiseaseNational Center For Research Resources1995
  • Role Of Vgr-1/Bmp-6 In Chondrogenesis And OsteogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1993
  • Transcriptional Regulation Of P450 C17 GeneNational Institute Of Diabetes And Digestive And Kidney Diseases1989

Hospital Affiliations